XNAS
CLOV
Market cap2.37bUSD
Oct 08, Last price
4.58USD
1D
0.44%
1Q
3.15%
IPO
-55.66%
Name
Clover Health Investments Corp
Chart & performance
P/E
—
P/S
1.23
EPS
—
Div yield, %
—
Shrs. gr., 5y
5.04%
Rev. gr., 5y
23.39%
Revenues
1.92b
+40.34%
Net income
-86m
L+98.91%
CFO
-67m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
Key people
Andrew Toy
Chief Executive Officer, Co-Founder, Director · since 2023
Chief Financial Officer · since 2024
Brady Priest
Chief Executive Officer of Home Care · since 2022
Jamie Reynoso
Chief Executive Officer of Medicare Advantage · since 2023
Aric Sharp
Chief Executive Officer of Value-Based Care · since 2022
Conrad Wai
Chief Technology Officer · since 2022
Karen Soares
General Counsel, Corporate Secretary · since 2023
Vivek Garipalli
Executive Chairperson, Co-Founder · since 2023
Shelly Gupta
Chief Medical Officer · since 2025
Independent Director · since 2021
Carladenise Edwards
Independent Director · since 2022
Demetrios Kouzoukas
Lead Independent Director · since 2023
Anna Loengard
Independent Director · since 2022
Independent Director · since 2021
Thomas Tran
Independent Director · since 2024
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
725 COOL SPRINGS BLVD
SUITE 320
Franklin, TN 37067
US
SUITE 320
Franklin, TN 37067
US
Previous name
Social Capital Hedosophia Holdings Corp. III
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||